Answers are grounded in this paper and cite their sources.
Cohort analysis demonstrates tafamidis effects on left ventricular strain in transthyretin amyloidosis with diabetes, highlighting metabolic influences on cardiac response.
Background: Tafamidis is used in patients with wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), but the effect of diabetes mellitus (DM) on the efficacy of tafamidis is unknown.
No takes yet. Share an insight, caveat, or question.
Tsurukawa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: